About three times as many eczema patients on nemolizumab had itch relief within two days compared to placebo Twice as many eczema patients slept better within two days FRIDAY, Dec. 19, 2025 (HealthDay ...
A drug approved to treat eczema provided significant improvement in the symptoms of patients with severe itching diseases that currently have no targeted treatments, according to a new study. The drug ...
Apogee Therapeutics Inc. (NASDAQ:APGE) stock is experiencing a significant surge, trading almost 29% higher in premarket on Monday. This substantial increase in stock price follows the release of ...
Patients with primary biliary cholangitis and moderate-to-severe pruritus who received seladelpar over 6 months experienced a ...
An Ipsen drug developed to treat the severe itching that accompanies certain liver disorders is now FDA approved for treating this complication in patients with Alagille syndrome. It’s the second ...
A recently approved injectable eczema drug provides quick itch relief to patients with the maddening skin disease, a new study says. Nemolizumab (Nemluvio) relieved itchiness within two days for three ...
Nemolizumab (Nemluvio) relieved itchiness within two days for three times as many patients as a placebo, researchers reported Tuesday in the Journal of the European Academy of Dermatology and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback